News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

EastHORN Names Iain Gordon as New Global Head of Business Development

7/24/2013 10:10:42 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

July 24, 2013 -- Eastern European specialist contract research organization (CRO) EastHORN Clinical Services in CEE announces the appointment of Iain Gordon as its new Global Head of Business Development. Gordon has been closely involved in clinical research in CEE since the late 90’s and has been an integral part of the exponential growth in clinical trials that the region has enjoyed since then. During this period he was most recently at the Russian/Swiss CRO PSI, as Head of Business Development, Europe. Before that he was at Pharm-Olam, as VP of Commercial and Corporate Affairs, and prior to that spent 7 years at Inveresk Research. Based in the UK, Gordon is a 15-year veteran of CRO business development in Central and Eastern Europe.

Alan Wood, PhD, EastHORN’s Executive Chairman, said: “We are very pleased to have been able to attract a person of Iain Gordon’s calibre to lead our Business Development efforts. We have ambitious growth plans within our region and Iain will be a key player in our senior management team.”

Iain Gordon said: “I am delighted to be joining EastHORN at this important stage in the company’s development. Since joining the CRO industry in the 90's I have been continually impressed with the quality and speed of clinical work in CEE. In an industry where timelines are absolutely key, but deadlines are often missed, I have lost count of the times that CEE operations and sites have saved the day. As this region matures it now offers the best of both worlds, combining experience and dynamic enrolment, continually outperforming some of the more exotic and less predictable regions that have started to offer clinical services more recently."

Help employers find you! Check out all the jobs and post your resume.

Read at

comments powered by Disqus